Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in

Cough, Cold and Allergy (Hay Fever) Remedies in Israel

Nov 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

2020 IMPACT

Stockpiling in March and April is offset by slowdown as COVID-19 restrictions are eased

In 2020, cough, cold and allergy (hay fever) remedies is expected to see higher current value growth than in the previous year. Although sales of such products increased significantly during panic-buying in March and April due to COVID-19, demand saw a sharp slowdown, after cases declined and restrictions were lifted at the start of May.

Growth limited by the lack of flu cases, mainly as a result of COVID-19

The impact of stockpiling is expected to contribute to solid current value growth in 2020, although the rate of growth is not expected to be significantly different from that seen in 2019. This is because growth in cough, cold and allergy (hay fever) remedies is hampered by the lower number of flu and other viral illnesses in Israel than usual.

Teva Pharmaceutical Industries continues to lead, while GSK and Dexcel Pharma compete for second place and private label gains share in 2020

Teva Pharmaceutical Industries continues to lead in cough, cold and allergy (hay fever) remedies in 2020 thanks to its Acamol Tsinun and Teva-Cold, which are strong in combination products, and Alrin, which ranks second in nasal sprays. These brands are widely recognised and are often consumers' go-to products for congestion and colds.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Cough, Cold and Allergy Sample Report Cough, Cold and Allergy Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Israel with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Israel, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Israel market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Israel?
What are the major brands in Israel?
What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Cough, Cold and Allergy (Hay Fever) Remedies in Israel - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Stockpiling in March and April is offset by slowdown as COVID-19 restrictions are eased

Growth limited by the lack of flu cases, mainly as a result of COVID-19

Teva Pharmaceutical Industries continues to lead, while GSK and Dexcel Pharma compete for second place and private label gains share in 2020

RECOVERY AND OPPORTUNITIES

Stable growth forecast, driven by combination products - cough, cold and allergy (hay fever) remedies

Growth in nasal sprays as saltwater sprays largely used for children

Growth to slow as winters return to more normal patterns

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025

Consumer Health in Israel - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Distribution of Consumer Health by Format: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format and Category: % Value 2020
Table 15 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

Megatrends

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in Israel

New Report Guarantee

Executive Summary

New Report Guarantee

2020 IMPACT

Stockpiling in March and April is offset by slowdown as COVID-19 restrictions are eased

Growth limited by the lack of flu cases, mainly as a result of COVID-19

Teva Pharmaceutical Industries continues to lead, while GSK and Dexcel Pharma compete for second place and private label gains share in 2020

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in Israel - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Stockpiling in March and April is offset by slowdown as COVID-19 restrictions are eased

Growth limited by the lack of flu cases, mainly as a result of COVID-19

Teva Pharmaceutical Industries continues to lead, while GSK and Dexcel Pharma compete for second place and private label gains share in 2020

RECOVERY AND OPPORTUNITIES

Stable growth forecast, driven by combination products - cough, cold and allergy (hay fever) remedies

Growth in nasal sprays as saltwater sprays largely used for children

Growth to slow as winters return to more normal patterns

CATEGORY DATA

Consumer Health in Israel - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports